Viewing Study NCT00135863



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00135863
Status: TERMINATED
Last Update Posted: 2015-05-21
First Post: 2005-08-25

Brief Title: MesoHep II Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
Sponsor: Ribe County Hospital
Organization: Ribe County Hospital

Study Overview

Official Title: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
Status: TERMINATED
Status Verified Date: 2004-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients with end stage renal disease ESRD who use peritoneal dialyses with PhysionealR Baxter AS Denmark were allocated to inject either placebo or tinzaparin daily into the morning dialysis bag Active medication as well as placebo was added for three months separated by a one month washout period At the beginning and end of each treatment period peritoneal equilibrations tests PE-tests KtV blood and dialysate samples were analyzed We the researchers at Ribe County Hospital set out to examine inflammation local and systemic nutrition and ultrafiltration
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2612-2459 None None None
2564-03 None None None